Increased non-prostate cancer death risk in clinically diagnosed prostate cancer

Department of Urology Public Health, Erasmus Medical Centre, Rotterdam Cancer Registry Rotterdam, Rotterdam, the Netherlands.
BJU International (Impact Factor: 3.53). 01/2012; 110(2):188-94. DOI: 10.1111/j.1464-410X.2011.10811.x
Source: PubMed


Study Type – Prognosis (case control)
Level of Evidence 3a
What's known on the subject? and What does the study add?
Treatment of advanced PC might put patients at an increased risk of cardiovascular events. Recent studies have suggested that the excess mortality is lower among men who were diagnosed with screen detected PC in comparison to men with clinically diagnosed PC, possibly due to the use of medications for cardiovascular disease and the change to a healthier lifestyle of men with a screen detected PC.
Men with clinically diagnosed PC have an increased risk of death unrelated to PC itself, i.e., the excess mortality is based on an increased risk of dying from other neoplasm and diseases of the circulatory or respiratory system.

Download full-text


Available from: Fritz H Schröder, Jan 01, 2014